WhiteLab Genomics

whitelabgx.com →

+204%

est. 2Y upside i

Series A

Unleashing the potential of DNA and RNA based therapies using AI

Rank

#44

Sector

TechBio

Est. Liquidity

~5Y

Data Quality

Data: Low

WhiteLab Genomics offers high potential upside (204% expected) but with significant risk and low confidence due to a stale Series A valuation and intense Big Tech competition.

Last updated: July 3, 2026

Bull (20%)+380%

AI platform achieves category leadership and enters IPO window. At 10x forward revenue ($194M exit), common stock sees 4.8x return before dilution. However, due to Series A stage cap, upside capped at +400%.

Base (35%)+407%

Revenue grows to $19.4M and exit multiple converges to 6x (mid of comps), yielding $116M exit value. After 20% dilution from expected Series B, net equity upside is +407%.

Bear (45%)-32%

Incumbent threat materializes, multiple compresses to 1x. Exit value of $19.4M barely exceeds $10.6M preference, leaving common with minimal residual. After dilution, downside of -32%.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

48%

With $10.6M in total funding against a $22.1M valuation, the preference overhang is 48%, meaning common equity is highly subordinated.

Dilution Risk

high

Given the stale round dating to 2022 and 52 employees, a Series B within 2 years is likely, diluting existing shareholders by approximately 20%.

Secondary Liquidity

none

No secondary transactions or markets exist for this private company; equity is locked until an exit (IPO or acquisition).

Other — 1 role

  • Careers · Paris, Boston, Montréal
View all 1 open roles at WhiteLab Genomics →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on WhiteLab Genomics's data — designed to show you've done your homework.

  • 1

    “How does WhiteLab plan to differentiate and defend against incumbents like Google DeepMind in AI-driven genomics?”

  • 2

    “What is the expected timeline to Series B and how does the current revenue trajectory inform that?”

  • 3

    “What is the company's strategy for converting pilot customers into long-term enterprise contracts?”

Community

Valuation Sentiment

Our model estimates +204% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.